Nuveen AA-BBB CLO ETF (NYSEARCA:NCLO – Get Free Report) was the target of a significant decline in short interest in the month of October. As of October 15th, there was short interest totaling 51,910 shares, a decline of 38.9% from the September 30th total of 84,960 shares. Currently, 0.6% of the shares of the company are short sold. Based on an average daily volume of 311,492 shares, the short-interest ratio is currently 0.2 days.
Nuveen AA-BBB CLO ETF Stock Performance
Shares of NCLO traded down $0.16 on Monday, reaching $24.92. 50,232 shares of the stock traded hands, compared to its average volume of 59,325. The stock’s 50-day moving average price is $25.05 and its 200-day moving average price is $25.00. Nuveen AA-BBB CLO ETF has a 12 month low of $24.22 and a 12 month high of $25.36.
Hedge Funds Weigh In On Nuveen AA-BBB CLO ETF
Institutional investors have recently modified their holdings of the stock. TSG Advice Partners LLC acquired a new position in Nuveen AA-BBB CLO ETF during the third quarter valued at approximately $614,000. Victory Financial Group LLC boosted its holdings in shares of Nuveen AA-BBB CLO ETF by 124.2% during the 3rd quarter. Victory Financial Group LLC now owns 20,121 shares of the company’s stock worth $504,000 after buying an additional 11,145 shares during the period. Hidden Cove Wealth Management LLC bought a new stake in Nuveen AA-BBB CLO ETF in the 3rd quarter valued at $1,376,000. Elevated Financial Group LLC acquired a new position in Nuveen AA-BBB CLO ETF in the 3rd quarter valued at $7,216,000. Finally, Integrated Wealth Concepts LLC acquired a new position in Nuveen AA-BBB CLO ETF in the 2nd quarter valued at $112,000.
About Nuveen AA-BBB CLO ETF
The Nuveen AA-BBB CLO ETF (NCLO) is an exchange-traded fund that mostly invests in investment grade fixed income. The fund is actively managed, seeking total return through investments in USD-denominated, investment-grade collateralized loan obligations (CLOs) of any maturity. NCLO was launched on Dec 10, 2024 and is issued by Nuveen.
Recommended Stories
- Five stocks we like better than Nuveen AA-BBB CLO ETF
- AbbVie’s Humira Era Is Fading, But Its New Growth Engines Face Another Test
- GLP-1 Focus or Broader Peptide Exposure: Which ETF Has the Edge?
- Mortgage Rates Froze U.S. Housing, But These 3 Overseas Markets Still Pay Double Digits
- Big Tech Is Spending Billions on AI—These 5 Stocks Are Getting Paid
Receive News & Ratings for Nuveen AA-BBB CLO ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nuveen AA-BBB CLO ETF and related companies with MarketBeat.com's FREE daily email newsletter.
